4//SEC Filing
ORCHID CELLMARK INC 4
Accession 0000920148-11-000101
CIK 0001107216operating
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 10:00 AM ET
Size
7.7 KB
Accession
0000920148-11-000101
Insider Transaction Report
Form 4
LABORATORY CORP OF AMERICA HOLDINGS
10% Owner
Transactions
- Purchase
Common Stock, par value $.001
2011-12-14$2.80/sh+134,943$377,840→ 26,130,959 total(indirect: See footnote) - Purchase
Common Stock, par value $.001
2011-12-13$2.80/sh+30,304$84,851→ 25,996,016 total(indirect: See footnote)
Footnotes (1)
- [F1]The Reporting Person is filing this Form 4 on behalf of itself and OCM Acquisition Corp. ("OCM"), a Delaware corporation and a wholly owned subsidiary of the Reporting Person. The shares of common stock to which this Form 4 relates were acquired by OCM during the subsequent offering period of the tender offer for all outstanding shares of common stock of the Issuer, including, to the extent outstanding, the associated preferred stock purchase rights issued under the Rights Agreement, dated July 27, 2001, as amended, between the Issuer and American Stock Transfer & Trust Company, as rights agent (the "Offer"). The Offer was made upon the terms and subject to the conditions set forth in the Offer to Purchase, dated April 19, 2011, which was annexed to and filed with the Schedule TO filed by the Reporting Person with the Securities and Exchange Commission on April 19, 2011.
Documents
Issuer
ORCHID CELLMARK INC
CIK 0001107216
Entity typeoperating
Related Parties
1- filerCIK 0001107216
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 10:00 AM ET
- Size
- 7.7 KB